Ganglioneuroblastoma
📧 Sign up to get email alerts when something new happens for Ganglioneuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma [Phase 3]
A Phase 3 trial is recruiting to test dinutuximab plus chemotherapy, surgery, and stem cell transplantation for newly diagnosed high-risk ne…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse [Phase 1, Phase 2]
Clinical trial update describing the addition of iberdomide to therapy for neuroblastoma that has recurred or is refractory, in Phase 1/2 an…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors [EARLY_Phase 1]
A Mayo Clinic-sponsored early-phase 1 trial is evaluating 68Ga-DOTATATE PET/CT as a diagnostic tool for pediatric metastatic neuroendocrine …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma [Phase 2]
This clinical trial update describes a Phase 2 study comparing 123I-MIBG and 18F-MFBG imaging in patients with newly diagnosed, high-risk ne…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) [Phase 3]
This clinical trial update describes a Phase 3 study evaluating adding 131I-MIBG or lorlatinib to intensive therapy for high-risk neuroblast…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma [Phase 3]
A Phase 3 clinical trial in pediatric patients with refractory or relapsed high-risk neuroblastoma and ganglioneuroblastoma is evaluating ch…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Phase II Study of Proton Radiation Therapy for Neuroblastoma [NA]
A Phase II clinical trial is evaluating proton radiation therapy for neuroblastoma and related ganglioneuroblastoma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma [Phase 3]
A Phase 3 clinical trial update investigates response and biology-based risk-factor guided therapy for younger patients with non-high risk n…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
This clinical trial update describes biomarker analysis in tumor tissue from patients with newly diagnosed neuroblastoma or ganglioneuroblas…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours [NA]
The SIOPEN BIOPORTAL is an international registry connected to a virtual biobank for patients with peripheral neuroblastic tumors, with recr…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 [Phase 1]
Phase 1 clinical trial evaluating ENCIT-01, an engineered neuroblastoma cellular immunotherapy, in patients with neuroblastoma or ganglioneu…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification
This clinical trial update reports ongoing recruitment for a study stratifying risk factors in abdominal neuroblastoma patients undergoing l…